IPO registrations (S-1, F-1) · Registrants
TRANSCEND THERAPEUTICS INC
- SEC CIK
- 1020910 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1996-08-22, last 1997-07-02; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 1997-07-07; withdrawal requested 1996-12-18
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 738 MAIN STREET, SUITE 431, Waltham, MA 02451
- EIN
- 04-3174575
- EDGAR entity type
- operating
Offering terms
- Final price
- $1.20 per share (424B1 filed 1997-07-07, an initial public offering)
- Shares sold
- 1,800,000
- Gross proceeds
- $2,160,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TSND
- Lead underwriters
- EVEREN Securities, Inc (756,250 shares); Principal Financial Securities, Inc (453,750 shares)
- Syndicate
- EVEREN Securities, Inc. Principal Financial Securities, Inc; Cowen (50,000); Credit Suisse (50,000); Lehman Brothers (50,000); UBS (50,000); Adams Harkness (30,000); Advest, Inc (30,000); J.C. Bradford & Co (30,000); Genesis Merchant Group Securities (30,000); Janney Montgomery Scott (30,000); Leerink Partners (30,000); Mesirow Financial, Inc (30,000); Nesbitt Burns Securities Inc (30,000); Piper Sandler (30,000); Prime Charter Ltd (30,000); Raymond James (30,000); Sutro & Co. Incorporated (30,000); Wheat, First Securities, Inc (30,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-08-22 | S-1 | S-1 (registration) | TRANSCEND THERAPEUTICS INC | 0000950135-96-003775 ↗ |
| 1996-12-18 | RW | RW (withdrawal request) | TRANSCEND THERAPEUTICS INC | 0000950135-96-005332 ↗ |
| 1997-03-05 | S-1 | S-1 (registration) | TRANSCEND THERAPEUTICS INC | 0000950135-97-001078 ↗ |
| 1997-03-18 | S-1/A | S-1/A (amendment) | TRANSCEND THERAPEUTICS INC | 0000950135-97-001240 ↗ |
| 1997-04-10 | S-1/A | S-1/A (amendment) | TRANSCEND THERAPEUTICS INC | 0000950135-97-001776 ↗ |
| 1997-06-06 | S-1/A | S-1/A (amendment) | TRANSCEND THERAPEUTICS INC | 0000950135-97-002637 ↗ |
| 1997-06-30 | S-1/A | S-1/A (amendment) | TRANSCEND THERAPEUTICS INC | 0000950135-97-002867 ↗ |
| 1997-07-01 | S-1/A | S-1/A (amendment) | TRANSCEND THERAPEUTICS INC | 0000950135-97-002901 ↗ |
| 1997-07-02 | S-1/A | S-1/A (amendment) | TRANSCEND THERAPEUTICS INC | 0000950135-97-002907 ↗ |
| 1997-07-07 | 424B1 | 424B1 (final prospectus) | TRANSCEND THERAPEUTICS INC | 0000950135-97-002922 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1997-07-02 | S-1/A | registration statement | $10.00 | 1,800,000 | $18,000,000 | Nasdaq TSND | 5 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 1, cover names 4 | document ↗ | |
| 1997-07-07 | 424B1 | final prospectus | $1.20 | 1,800,000 | $2,160,000 | Nasdaq TSND | 20 | from the submission text; price line, shares headline, proceeds computed, underwriting table 19, cover names 1 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), MA first:
- Eloxx Pharmaceuticals, Inc. MA
- PANACOS PHARMACEUTICALS, INC. MA
- CHARLES RIVER LABORATORIES INC MA
- AGENUS INC MA
- CURIS INC MA
- MOMENTA PHARMACEUTICALS INC MA
- ACCELERON PHARMA INC MA
- bluebird bio, Inc. MA
- Altus Pharmaceuticals Inc. MA
- BioVex Group, Inc. MA
In other datasets, the same topic (Health) in MA:
- Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health